Stocks360

IM Cannabis Corp. (IMCC.CN)

Stock analysis · CNQ · Healthcare · Drug Manufacturers - Specialty & Generic

Share: Facebook X WhatsApp SMS

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
N/A
PE (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
N/A
Beta
3.17
Day Range
N/A
52-wk Range
N/A
Avg Volume
N/A
Volume
N/A

IM Cannabis Corp. (IMCC.CN) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent
Aug 14, 2025
EPS $-0.09 vs est. $-0.20
Beat by $0.10

Proprietary Signals

Signal snapshot temporarily unavailable.

About IM Cannabis Corp.

IM Cannabis Corp. is engaged in the cultivation, processing, and supply of medical cannabis products across its operational territories of Israel, Germany, and Canada. The company's product portfolio features cannabis flowers and distinctive, strain-specific extracts marketed under its IMC brand. Additionally, it offers dried flower, pre-rolls, and pressed hash through its WAGNERS and Highland Grow labels. IM Cannabis Corp. caters to a diverse customer base, including medical patients and adult-use recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.

Peers

Recent News

  • No recent news available.

Related

Browse more tickers: sitemap